UnitedHealth Ratings and Price Target Update by Wolfe Research

NewsNews
PostsPosts
SelectionSelection

- Davtan76Davtan76
  ·05-21
  Share your opinion about this news…
  UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks
  HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enou
  UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks
  1.22K Comment
  3
  Share
  Report
- Davtan76Davtan76
  ·05-21
  Share your opinion about this news…
  UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks
  HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enou
  UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks
  1.22K Comment
  3
  Share
  Report

{"themeInfo":{"themeId":"428461c81b85d0be506ea7b88cf8a2a2","name":"UnitedHealth Ratings and Price Target Update by Wolfe Research","description":"Wolfe Research maintained UnitedHealth at Outperform but cut the price target from $501.00 to $390.00 per share. The updated ratings and price target indicate a shift in the outlook for UnitedHealth's stock.","image":"https://community-static.tradeup.com/news/1201dcc0482be040348fb8d4f228bb68","type":2,"style":4,"follow":false,"createTime":1747759541376,"userCounts":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/special/finance&rndata={\"themeId\":428461c81b85d0be506ea7b88cf8a2a2}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowFollow":false,"hasReward":false,"rewardScore":0,"rewardValidDate":0,"rewardEnd":false,"symbols":["UNH"],"tweetCounts":1,"categoryId":"2929bb7468f5415f853fd96fb35d7c3b","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"UnitedHealth Ratings and Price Target Update by Wolfe Research","tweetAmount":1,"imageIsDefault":false,"aiDerivativeIssues":[]},"tab":"news","newsList":[{"id":266342,"article_id":"2537698675","title":"UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks","subtitle":"","subtitle_show":0,"pub_time":1747834790100,"source_id":"","language":"en","url":"https://www.investing.com/news/analyst-ratings/unitedhealth-stock-rating-cut-by-hsbc-to-reduce-target-to-270-93CH-4056217","is_publish_highlight":1,"symbols_score_info":{"UNH":0.9},"rights":null},{"id":266240,"article_id":"2537098055","title":"UnitedHealth Stock Slumps on HSBC Downgrade. A Recovery 'Could Be Delayed.' -- Barrons.com","subtitle":"","subtitle_show":0,"pub_time":1747828620000,"source_id":"dowjones_highlight","language":"en","url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":0,"symbols_score_info":{"00005":1,"HSBC":1,"UNH":1},"rights":null},{"id":266213,"article_id":"2537984407","title":"BUZZ-UnitedHealth falls after HSBC downgrade, PT cut","subtitle":"","subtitle_show":0,"pub_time":1747824565000,"source_id":"reuters_news_en","language":"en","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nL4N3RT0T5:1","is_publish_highlight":0,"symbols_score_info":{"UNH":0.9},"rights":null},{"id":266208,"article_id":"2537816569","title":"汇丰银行下调联合健康目标价至270美元","subtitle":"","subtitle_show":0,"pub_time":1747822503000,"source_id":"tencent","language":"zh","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052118172194fdd2d3&s=b","is_publish_highlight":0,"symbols_score_info":{"HSBC":1,"UNH":1},"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052118172194fdd2d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true}},{"id":266207,"article_id":"1121127361","title":"Stock Track | UnitedHealth Plunges 5% Pre-market Following HSBC Downgrade and Price Target Cut","subtitle":"","subtitle_show":0,"pub_time":1747822480309,"source_id":"ai_movement_en","language":"en","url":"","is_publish_highlight":0,"symbols_score_info":{"UNH":1},"rights":null},{"id":265938,"article_id":"2537867549","title":"UnitedHealth : HSBC Cuts to Reduce From Hold; Cuts Target Price to $270 From $490","subtitle":"","subtitle_show":0,"pub_time":1747821335525,"source_id":"reuters_en_live","language":"en","url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nFWN3RT25V:1","is_publish_highlight":0,"symbols_score_info":{"UNH":0.9},"rights":null},{"id":266209,"article_id":"2537882489","title":"HSBC Downgrades UnitedHealth Group to Reduce From Hold, Adjusts Price Target to $270 From $490","subtitle":"","subtitle_show":0,"pub_time":1747819244000,"source_id":"mtnewswires_news","language":"en","url":"https://www.mtnewswires.com/","is_publish_highlight":0,"symbols_score_info":{"00005":1,"HSBC":1,"UNH":1},"rights":null},{"id":264473,"article_id":"2537038644","title":"Wolfe Research：维持UnitedHealth Group评级","subtitle":"","subtitle_show":0,"pub_time":1747758773000,"source_id":"tencent","language":"zh","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521003537a485a698&s=b","is_publish_highlight":0,"symbols_score_info":{"UNH":1},"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521003537a485a698&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true}},{"id":264471,"article_id":"2537564425","title":"UnitedHealth Is Maintained at Outperform by Wolfe Research","subtitle":"","subtitle_show":0,"pub_time":1747758480000,"source_id":"dowjones_highlight","language":"en","url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":0,"symbols_score_info":{"UNH":1},"rights":null},{"id":264472,"article_id":"2537644285","title":"Wolfe Research：维持UnitedHealth Group(UNH.US)评级，由优于大市调整至优于大市评级, 目标价由501.00美元调整至390.00美元。","subtitle":"","subtitle_show":0,"pub_time":1747758218000,"source_id":"jinrongjie_stock","language":"zh","url":"https://24h.jrj.com.cn/2025/05/21002350547537.shtml","is_publish_highlight":0,"symbols_score_info":{"UNH":1},"rights":null}],"isFinancial":true,"allList":[{"id":437472294789224,"gmtCreate":1747835562814,"gmtModify":1747835813427,"author":{"id":"3580657869143830","authorId":"3580657869143830","name":"Davtan76","avatar":"https://static.tigerbbs.com/60997d3eaaf41929221c63aa8166c7f3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3580657869143830","idStr":"3580657869143830"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/437472294789224","repostId":"2537698675","repostType":2,"repost":{"id":"2537698675","kind":"live","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1747834790,"share":"https://ttm.financial/m/news/2537698675?lang=&edition=fundamental","pubTime":"2025-05-21 21:39","market":"us","language":"en","title":"UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2537698675","media":"Tiger Newspress","summary":"HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enou","content":"<html><head></head><body><p style=\"text-align: start;\">HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enough to buy given the risks to earnings head.</p><p style=\"text-align: start;\">The firm slashed UnitedHealth’s rating reduce from hold on Wednesday, and trimmed its price target to $270 per share from $490. HSBC’s forecast implies roughly 16% downside from Tuesday’s $321.58 close.</p><p style=\"text-align: start;\">Shares are down more than 36% in 2025, as UnitedHealth contends with multiple headwinds which include the exit of its CEO earlier this month as well as a Department of Justice investigation into allegations of fraud.</p><p>″[The] new CEO has opportunity to start on a clean(er) slate, but we see risk to earnings growth along with policy overhang,” analyst Sidharth Sahoo wrote on Wednesday.</p><p style=\"text-align: start;\">“While the bulls point to a 30% discount to historical P/E as an attractive entry point, we highlight three key reasons that could spoil the recovery journey,” added Sahoo, citing higher medical costs, political pressure on drug prices and lower overall profitability ahead, especially if there are cuts to Medicaid spending.</p><p style=\"text-align: start;\">The stock trades at a forward price-earnings ratio of just 13, near its lowest of the last 10 years, according to HSBC.</p><p style=\"text-align: start;\">UnitedHealth shares were down 5.3% in morning trading the HSBC call. The stock had garnered some interest recently from traders because of how deeply oversold the shares had become. The stock was up 10% since last Friday through Tuesday’s close.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/19fd136b025f543a695a9d7a7772947e\" tg-width=\"845\" tg-height=\"625\"/></p><p style=\"text-align: start;\">But HSBC thinks the fundamentals will deteriorate some more, further hitting the stock.</p><p style=\"text-align: start;\">“Regaining investor confidence by reminding of the vertically integrated value-based care offering can help UNH recover a part of the premium,” wrote the analyst. “But any further downward earnings revision would weigh on ROE and multiples.”</p><p>Meanwhile, UnitedHealth sank also following a Guardian investigation that claimed the healthcare giant secretly paid nursing homes bonuses to reduce hospital transfers and helped it gain Medicare enrollees.</p><p style=\"text-align: start;\">According to the Guardian report, the payments were part of a cost-cutting strategy embedded in UnitedHealth’s nursing home initiative, which deployed company medical teams to facilities across the country. These teams reportedly worked to limit hospitalizations.</p><p style=\"text-align: start;\">In some cases, the Guardian reported that “the company’s insertion of itself into nursing home emergency protocols helped delay or avert transfers for patients who could have benefited from immediate hospital care.”</p><p style=\"text-align: start;\">One man reportedly suffered permanent brain damage after a delayed transfer for a suspected stroke.</p><p style=\"text-align: start;\">The report cites internal documents, court filings, and whistleblower complaints alleging that UnitedHealth’s financial incentives led to delayed care and inappropriate pressure on staff to reduce hospital visits. </p><p style=\"text-align: start;\">“No one is truly investigating when a patient suffers harm,” a current UnitedHealth (NYSE:UNH) nurse practitioner told the Guardian.</p><p style=\"text-align: start;\">The Guardian said UnitedHealth denied the allegations, calling the claim that its staff blocked hospital transfers “verifiably false.” </p><p style=\"text-align: start;\">A former nurse practitioner, Maxwell Ollivant, told the Guardian he filed a congressional declaration urging the federal government to hold the company accountable.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2025-05-21 21:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: start;\">HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enough to buy given the risks to earnings head.</p><p style=\"text-align: start;\">The firm slashed UnitedHealth’s rating reduce from hold on Wednesday, and trimmed its price target to $270 per share from $490. HSBC’s forecast implies roughly 16% downside from Tuesday’s $321.58 close.</p><p style=\"text-align: start;\">Shares are down more than 36% in 2025, as UnitedHealth contends with multiple headwinds which include the exit of its CEO earlier this month as well as a Department of Justice investigation into allegations of fraud.</p><p>″[The] new CEO has opportunity to start on a clean(er) slate, but we see risk to earnings growth along with policy overhang,” analyst Sidharth Sahoo wrote on Wednesday.</p><p style=\"text-align: start;\">“While the bulls point to a 30% discount to historical P/E as an attractive entry point, we highlight three key reasons that could spoil the recovery journey,” added Sahoo, citing higher medical costs, political pressure on drug prices and lower overall profitability ahead, especially if there are cuts to Medicaid spending.</p><p style=\"text-align: start;\">The stock trades at a forward price-earnings ratio of just 13, near its lowest of the last 10 years, according to HSBC.</p><p style=\"text-align: start;\">UnitedHealth shares were down 5.3% in morning trading the HSBC call. The stock had garnered some interest recently from traders because of how deeply oversold the shares had become. The stock was up 10% since last Friday through Tuesday’s close.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/19fd136b025f543a695a9d7a7772947e\" tg-width=\"845\" tg-height=\"625\"/></p><p style=\"text-align: start;\">But HSBC thinks the fundamentals will deteriorate some more, further hitting the stock.</p><p style=\"text-align: start;\">“Regaining investor confidence by reminding of the vertically integrated value-based care offering can help UNH recover a part of the premium,” wrote the analyst. “But any further downward earnings revision would weigh on ROE and multiples.”</p><p>Meanwhile, UnitedHealth sank also following a Guardian investigation that claimed the healthcare giant secretly paid nursing homes bonuses to reduce hospital transfers and helped it gain Medicare enrollees.</p><p style=\"text-align: start;\">According to the Guardian report, the payments were part of a cost-cutting strategy embedded in UnitedHealth’s nursing home initiative, which deployed company medical teams to facilities across the country. These teams reportedly worked to limit hospitalizations.</p><p style=\"text-align: start;\">In some cases, the Guardian reported that “the company’s insertion of itself into nursing home emergency protocols helped delay or avert transfers for patients who could have benefited from immediate hospital care.”</p><p style=\"text-align: start;\">One man reportedly suffered permanent brain damage after a delayed transfer for a suspected stroke.</p><p style=\"text-align: start;\">The report cites internal documents, court filings, and whistleblower complaints alleging that UnitedHealth’s financial incentives led to delayed care and inappropriate pressure on staff to reduce hospital visits. </p><p style=\"text-align: start;\">“No one is truly investigating when a patient suffers harm,” a current UnitedHealth (NYSE:UNH) nurse practitioner told the Guardian.</p><p style=\"text-align: start;\">The Guardian said UnitedHealth denied the allegations, calling the claim that its staff blocked hospital transfers “verifiably false.” </p><p style=\"text-align: start;\">A former nurse practitioner, Maxwell Ollivant, told the Guardian he filed a congressional declaration urging the federal government to hold the company accountable.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","IE00BN29S564.USD":"JANUS HENDERSON BALANCED \"A3\" (USD) INC","IE00B775H168.HKD":"JANUS HENDERSON BALANCED \"A5M\" (HKD) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","BK4534":"瑞士信贷持仓","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU1069347547.HKD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (HKD) INC","LU1153585028.USD":"BGF GLOBAL LONG-HORIZON EQUITY  \"A4\" (USD) INC","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","IE00BZ9MQY76.HKD":"FTGF CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (HKD) ACC","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","SG9999017495.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"B\" (SGD) ACC","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","SGXZ81514606.USD":"大华环球创新基金A Acc USD","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU0238689110.USD":"贝莱德环球动力股票基金","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1934455863.HKD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (HKD) ACC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","UNH":"联合健康","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0079474960.USD":"联博美国增长基金A","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC"},"source_url":"https://www.investing.com/news/analyst-ratings/unitedhealth-stock-rating-cut-by-hsbc-to-reduce-target-to-270-93CH-4056217","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2537698675","content_text":"HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enough to buy given the risks to earnings head.The firm slashed UnitedHealth’s rating reduce from hold on Wednesday, and trimmed its price target to $270 per share from $490. HSBC’s forecast implies roughly 16% downside from Tuesday’s $321.58 close.Shares are down more than 36% in 2025, as UnitedHealth contends with multiple headwinds which include the exit of its CEO earlier this month as well as a Department of Justice investigation into allegations of fraud.″[The] new CEO has opportunity to start on a clean(er) slate, but we see risk to earnings growth along with policy overhang,” analyst Sidharth Sahoo wrote on Wednesday.“While the bulls point to a 30% discount to historical P/E as an attractive entry point, we highlight three key reasons that could spoil the recovery journey,” added Sahoo, citing higher medical costs, political pressure on drug prices and lower overall profitability ahead, especially if there are cuts to Medicaid spending.The stock trades at a forward price-earnings ratio of just 13, near its lowest of the last 10 years, according to HSBC.UnitedHealth shares were down 5.3% in morning trading the HSBC call. The stock had garnered some interest recently from traders because of how deeply oversold the shares had become. The stock was up 10% since last Friday through Tuesday’s close.But HSBC thinks the fundamentals will deteriorate some more, further hitting the stock.“Regaining investor confidence by reminding of the vertically integrated value-based care offering can help UNH recover a part of the premium,” wrote the analyst. “But any further downward earnings revision would weigh on ROE and multiples.”Meanwhile, UnitedHealth sank also following a Guardian investigation that claimed the healthcare giant secretly paid nursing homes bonuses to reduce hospital transfers and helped it gain Medicare enrollees.According to the Guardian report, the payments were part of a cost-cutting strategy embedded in UnitedHealth’s nursing home initiative, which deployed company medical teams to facilities across the country. These teams reportedly worked to limit hospitalizations.In some cases, the Guardian reported that “the company’s insertion of itself into nursing home emergency protocols helped delay or avert transfers for patients who could have benefited from immediate hospital care.”One man reportedly suffered permanent brain damage after a delayed transfer for a suspected stroke.The report cites internal documents, court filings, and whistleblower complaints alleging that UnitedHealth’s financial incentives led to delayed care and inappropriate pressure on staff to reduce hospital visits. “No one is truly investigating when a patient suffers harm,” a current UnitedHealth (NYSE:UNH) nurse practitioner told the Guardian.The Guardian said UnitedHealth denied the allegations, calling the claim that its staff blocked hospital transfers “verifiably false.” A former nurse practitioner, Maxwell Ollivant, told the Guardian he filed a congressional declaration urging the federal government to hold the company accountable.","news_type":1,"symbols_score_info":{"UNH":0.9}},"isVote":1,"tweetType":1,"viewCount":1220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"essenList":[{"id":437472294789224,"gmtCreate":1747835562814,"gmtModify":1747835813427,"author":{"id":"3580657869143830","authorId":"3580657869143830","name":"Davtan76","avatar":"https://static.tigerbbs.com/60997d3eaaf41929221c63aa8166c7f3","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"3580657869143830","idStr":"3580657869143830"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/437472294789224","repostId":"2537698675","repostType":2,"repost":{"id":"2537698675","kind":"live","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1747834790,"share":"https://ttm.financial/m/news/2537698675?lang=&edition=fundamental","pubTime":"2025-05-21 21:39","market":"us","language":"en","title":"UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2537698675","media":"Tiger Newspress","summary":"HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enou","content":"<html><head></head><body><p style=\"text-align: start;\">HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enough to buy given the risks to earnings head.</p><p style=\"text-align: start;\">The firm slashed UnitedHealth’s rating reduce from hold on Wednesday, and trimmed its price target to $270 per share from $490. HSBC’s forecast implies roughly 16% downside from Tuesday’s $321.58 close.</p><p style=\"text-align: start;\">Shares are down more than 36% in 2025, as UnitedHealth contends with multiple headwinds which include the exit of its CEO earlier this month as well as a Department of Justice investigation into allegations of fraud.</p><p>″[The] new CEO has opportunity to start on a clean(er) slate, but we see risk to earnings growth along with policy overhang,” analyst Sidharth Sahoo wrote on Wednesday.</p><p style=\"text-align: start;\">“While the bulls point to a 30% discount to historical P/E as an attractive entry point, we highlight three key reasons that could spoil the recovery journey,” added Sahoo, citing higher medical costs, political pressure on drug prices and lower overall profitability ahead, especially if there are cuts to Medicaid spending.</p><p style=\"text-align: start;\">The stock trades at a forward price-earnings ratio of just 13, near its lowest of the last 10 years, according to HSBC.</p><p style=\"text-align: start;\">UnitedHealth shares were down 5.3% in morning trading the HSBC call. The stock had garnered some interest recently from traders because of how deeply oversold the shares had become. The stock was up 10% since last Friday through Tuesday’s close.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/19fd136b025f543a695a9d7a7772947e\" tg-width=\"845\" tg-height=\"625\"/></p><p style=\"text-align: start;\">But HSBC thinks the fundamentals will deteriorate some more, further hitting the stock.</p><p style=\"text-align: start;\">“Regaining investor confidence by reminding of the vertically integrated value-based care offering can help UNH recover a part of the premium,” wrote the analyst. “But any further downward earnings revision would weigh on ROE and multiples.”</p><p>Meanwhile, UnitedHealth sank also following a Guardian investigation that claimed the healthcare giant secretly paid nursing homes bonuses to reduce hospital transfers and helped it gain Medicare enrollees.</p><p style=\"text-align: start;\">According to the Guardian report, the payments were part of a cost-cutting strategy embedded in UnitedHealth’s nursing home initiative, which deployed company medical teams to facilities across the country. These teams reportedly worked to limit hospitalizations.</p><p style=\"text-align: start;\">In some cases, the Guardian reported that “the company’s insertion of itself into nursing home emergency protocols helped delay or avert transfers for patients who could have benefited from immediate hospital care.”</p><p style=\"text-align: start;\">One man reportedly suffered permanent brain damage after a delayed transfer for a suspected stroke.</p><p style=\"text-align: start;\">The report cites internal documents, court filings, and whistleblower complaints alleging that UnitedHealth’s financial incentives led to delayed care and inappropriate pressure on staff to reduce hospital visits. </p><p style=\"text-align: start;\">“No one is truly investigating when a patient suffers harm,” a current UnitedHealth (NYSE:UNH) nurse practitioner told the Guardian.</p><p style=\"text-align: start;\">The Guardian said UnitedHealth denied the allegations, calling the claim that its staff blocked hospital transfers “verifiably false.” </p><p style=\"text-align: start;\">A former nurse practitioner, Maxwell Ollivant, told the Guardian he filed a congressional declaration urging the federal government to hold the company accountable.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnitedHealth Shares Sink on HSBC Downgrade and Nursing Home Kickbacks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2025-05-21 21:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: start;\">HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enough to buy given the risks to earnings head.</p><p style=\"text-align: start;\">The firm slashed UnitedHealth’s rating reduce from hold on Wednesday, and trimmed its price target to $270 per share from $490. HSBC’s forecast implies roughly 16% downside from Tuesday’s $321.58 close.</p><p style=\"text-align: start;\">Shares are down more than 36% in 2025, as UnitedHealth contends with multiple headwinds which include the exit of its CEO earlier this month as well as a Department of Justice investigation into allegations of fraud.</p><p>″[The] new CEO has opportunity to start on a clean(er) slate, but we see risk to earnings growth along with policy overhang,” analyst Sidharth Sahoo wrote on Wednesday.</p><p style=\"text-align: start;\">“While the bulls point to a 30% discount to historical P/E as an attractive entry point, we highlight three key reasons that could spoil the recovery journey,” added Sahoo, citing higher medical costs, political pressure on drug prices and lower overall profitability ahead, especially if there are cuts to Medicaid spending.</p><p style=\"text-align: start;\">The stock trades at a forward price-earnings ratio of just 13, near its lowest of the last 10 years, according to HSBC.</p><p style=\"text-align: start;\">UnitedHealth shares were down 5.3% in morning trading the HSBC call. The stock had garnered some interest recently from traders because of how deeply oversold the shares had become. The stock was up 10% since last Friday through Tuesday’s close.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/19fd136b025f543a695a9d7a7772947e\" tg-width=\"845\" tg-height=\"625\"/></p><p style=\"text-align: start;\">But HSBC thinks the fundamentals will deteriorate some more, further hitting the stock.</p><p style=\"text-align: start;\">“Regaining investor confidence by reminding of the vertically integrated value-based care offering can help UNH recover a part of the premium,” wrote the analyst. “But any further downward earnings revision would weigh on ROE and multiples.”</p><p>Meanwhile, UnitedHealth sank also following a Guardian investigation that claimed the healthcare giant secretly paid nursing homes bonuses to reduce hospital transfers and helped it gain Medicare enrollees.</p><p style=\"text-align: start;\">According to the Guardian report, the payments were part of a cost-cutting strategy embedded in UnitedHealth’s nursing home initiative, which deployed company medical teams to facilities across the country. These teams reportedly worked to limit hospitalizations.</p><p style=\"text-align: start;\">In some cases, the Guardian reported that “the company’s insertion of itself into nursing home emergency protocols helped delay or avert transfers for patients who could have benefited from immediate hospital care.”</p><p style=\"text-align: start;\">One man reportedly suffered permanent brain damage after a delayed transfer for a suspected stroke.</p><p style=\"text-align: start;\">The report cites internal documents, court filings, and whistleblower complaints alleging that UnitedHealth’s financial incentives led to delayed care and inappropriate pressure on staff to reduce hospital visits. </p><p style=\"text-align: start;\">“No one is truly investigating when a patient suffers harm,” a current UnitedHealth (NYSE:UNH) nurse practitioner told the Guardian.</p><p style=\"text-align: start;\">The Guardian said UnitedHealth denied the allegations, calling the claim that its staff blocked hospital transfers “verifiably false.” </p><p style=\"text-align: start;\">A former nurse practitioner, Maxwell Ollivant, told the Guardian he filed a congressional declaration urging the federal government to hold the company accountable.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","IE00BN29S564.USD":"JANUS HENDERSON BALANCED \"A3\" (USD) INC","IE00B775H168.HKD":"JANUS HENDERSON BALANCED \"A5M\" (HKD) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","IE00BFSS7M15.SGD":"Janus Henderson Balanced A Acc SGD-H","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","BK4534":"瑞士信贷持仓","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU1069347547.HKD":"AB SICAV I - GLOBAL VALUE PORTFOLIO \"AD\" (HKD) INC","LU1153585028.USD":"BGF GLOBAL LONG-HORIZON EQUITY  \"A4\" (USD) INC","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","IE00BZ9MQY76.HKD":"FTGF CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (HKD) ACC","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","SG9999017495.SGD":"UGDP UNITED GLOBAL QUALITY GROWTH \"B\" (SGD) ACC","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","SGXZ81514606.USD":"大华环球创新基金A Acc USD","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU1003077747.HKD":"BGF GLOBAL EQUITY INCOME \"A6\" (HKDHDG) INC","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU0553294199.USD":"BGF GLOBAL EQUITY INCOME \"A5G\" (USD) INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU0672654240.SGD":"FTIF - Franklin US Opportunities A Acc SGD-H1","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU0238689110.USD":"贝莱德环球动力股票基金","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1934455863.HKD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (HKD) ACC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","LU0545039389.USD":"BGF GLOBAL EQUITY INCOME \"A2\" ACC","UNH":"联合健康","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU0079474960.USD":"联博美国增长基金A","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","LU2361045086.USD":"WELLINGTON US QUALITY GROWTH \"A\" (USD) ACC"},"source_url":"https://www.investing.com/news/analyst-ratings/unitedhealth-stock-rating-cut-by-hsbc-to-reduce-target-to-270-93CH-4056217","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2537698675","content_text":"HSBC downgraded UnitedHealth shares, saying the recent rout has still not made the shares cheap enough to buy given the risks to earnings head.The firm slashed UnitedHealth’s rating reduce from hold on Wednesday, and trimmed its price target to $270 per share from $490. HSBC’s forecast implies roughly 16% downside from Tuesday’s $321.58 close.Shares are down more than 36% in 2025, as UnitedHealth contends with multiple headwinds which include the exit of its CEO earlier this month as well as a Department of Justice investigation into allegations of fraud.″[The] new CEO has opportunity to start on a clean(er) slate, but we see risk to earnings growth along with policy overhang,” analyst Sidharth Sahoo wrote on Wednesday.“While the bulls point to a 30% discount to historical P/E as an attractive entry point, we highlight three key reasons that could spoil the recovery journey,” added Sahoo, citing higher medical costs, political pressure on drug prices and lower overall profitability ahead, especially if there are cuts to Medicaid spending.The stock trades at a forward price-earnings ratio of just 13, near its lowest of the last 10 years, according to HSBC.UnitedHealth shares were down 5.3% in morning trading the HSBC call. The stock had garnered some interest recently from traders because of how deeply oversold the shares had become. The stock was up 10% since last Friday through Tuesday’s close.But HSBC thinks the fundamentals will deteriorate some more, further hitting the stock.“Regaining investor confidence by reminding of the vertically integrated value-based care offering can help UNH recover a part of the premium,” wrote the analyst. “But any further downward earnings revision would weigh on ROE and multiples.”Meanwhile, UnitedHealth sank also following a Guardian investigation that claimed the healthcare giant secretly paid nursing homes bonuses to reduce hospital transfers and helped it gain Medicare enrollees.According to the Guardian report, the payments were part of a cost-cutting strategy embedded in UnitedHealth’s nursing home initiative, which deployed company medical teams to facilities across the country. These teams reportedly worked to limit hospitalizations.In some cases, the Guardian reported that “the company’s insertion of itself into nursing home emergency protocols helped delay or avert transfers for patients who could have benefited from immediate hospital care.”One man reportedly suffered permanent brain damage after a delayed transfer for a suspected stroke.The report cites internal documents, court filings, and whistleblower complaints alleging that UnitedHealth’s financial incentives led to delayed care and inappropriate pressure on staff to reduce hospital visits. “No one is truly investigating when a patient suffers harm,” a current UnitedHealth (NYSE:UNH) nurse practitioner told the Guardian.The Guardian said UnitedHealth denied the allegations, calling the claim that its staff blocked hospital transfers “verifiably false.” A former nurse practitioner, Maxwell Ollivant, told the Guardian he filed a congressional declaration urging the federal government to hold the company accountable.","news_type":1,"symbols_score_info":{"UNH":0.9}},"isVote":1,"tweetType":1,"viewCount":1220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"allBottom":false,"essenBottom":false}